Oragenics Launches Animal Study For COVID-19 Vaccine Candidate
Oragenics Inc (NYSE:OGEN) has initiated a hamster challenge study to evaluate the immunogenicity and viral load reduction impact of its COVID-19…
48 Biggest Movers From Yesterday
Gainers
RenovoRx, Inc. (NASDAQ: RNXT) climbed 107.8% to close at $16.02 on Monday after the company was granted FDA clearance for ‘Catheter, Intravascular Occluding, Temporary.’ The company recently priced its IPO at $9 per unit.
Oragenics Announces The Stabilized Pre-Fusion Spike Protein Trimer Produced By Its Canadian Collaborator And Licensed By The Company From The National Institutes Of Health Generates Neutralizing Antibodies In Mice After Immunization Against SARS-CoV-2
New data supports Company's approach to COVID-19 vaccine development.
Oragenics, Inc. (NYSE:OGEN) (the Company) announces that the stabilized pre-fusion spike protein trimer produced by its Canadian
